Anti-psychotic drugs reverse multidrug resistance of tumor cell lines and human AML cells ex-vivo
- 25 May 1999
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 139 (1) , 115-119
- https://doi.org/10.1016/s0304-3835(99)00020-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.Journal of Clinical Investigation, 1996
- Behavior of N-acylated daunorubicins in MDR1 gene transfected and parental cellsBiochemical Pharmacology, 1995
- Multidrug resistance is more than MDR1 activityLeukemia Research, 1995
- Cytochalasin D Modulates CD4 Crosslinking Sensitive Mitogenic Signal in T LymphocytesCellular Immunology, 1994
- Phase I and pharmacokinetics studies of prochlorperazine 2-h i.v. infusion as a doxorubicin-efflux blockerCancer Chemotherapy and Pharmacology, 1994
- Successful control of intractable nausea and vomiting requiring combined ondansetron and haloperidol in a patient with advanced cancerJournal of Pain and Symptom Management, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Types and causes of pain in cancer of the head and neckCancer, 1992
- Delirium in Cancer PatientsInternational Psychogeriatrics, 1991
- Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multidrug-resistant cellsExperimental Cell Research, 1991